Back to Home

Satellite Symposia at the Annual Radiation Oncology Meeting

September 28-29, 2024

Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal is Cure

Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal is Cure

Date: September 28, 2024
Location: Marriott Marquis Washington, D.C. & Virtual
Meeting Room: Liberty Ballroom MNOP
Time: 6:15 PM - 8:45 PM ET

View Details

New Frontiers in Immunotherapy for SCLC: Insights from Latest Clinical Trials and Their Application in Real-World Treatment

New Frontiers in Immunotherapy for SCLC: Insights from Latest Clinical Trials and Their Application in Real-World Treatment

Date: September 29, 2024
Location: Marriott Marquis Washington, D.C. & Virtual
Meeting Room: Marquis Ballroom 3-4
Time: 6:00 PM - 8:30 PM ET

View Details

The American Society for Radiation Oncology (ASTRO) has reviewed and approved this symposium as appropriate for presentation as an Industry Satellite Symposium. The symposium constitutes the content and views of the provider and is not part of the official ASTRO Annual Meeting program.

Event Details

  • Start Date
    September 28, 2024
  • End Date
    September 29, 2024
  • Location
    Washington, D.C. & Virtual
  • Venue
    Marriott Marquis
    Washington, D.C.
  • Target Audience
    This educational activity is directed toward radiation oncologists and other oncology healthcare professionals interested in NSCLC & SCLC.